Asset Details
Do you wish to reserve the book?
重组人白细胞介素-4对人肺腺癌细胞SPC-A1／TAX化疗增敏研究
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
重组人白细胞介素-4对人肺腺癌细胞SPC-A1／TAX化疗增敏研究
Do you wish to request the book?
重组人白细胞介素-4对人肺腺癌细胞SPC-A1／TAX化疗增敏研究
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
重组人白细胞介素-4对人肺腺癌细胞SPC-A1／TAX化疗增敏研究
2005
Overview
近年来肺癌的发病率和死亡率呈明显上升趋势，严重威胁着人民的健康。在肺癌的综合治疗中，化疗起着不可替代的作用，然而，肺癌细胞多药耐药性(MDR)的产生，严重制约了肺癌化疗的效果，是引起肺癌化疗失败的关键因素。肺癌细胞多药耐药性是目前临床难以克服的课题之一，研究其产生机制并进一步寻求逆转方法，从而选择有针对性的化疗药物是临床迫切需要的。近年研究表明，rhIL-4能诱导癌细胞分化，增加某些肿瘤细胞对化疗药物的敏感性，从而降低MDR。
